Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Newborn metabolic screening adds immunodeficiency test
Newborn metabolic screening adds immunodeficiency test

This month sees a change to the targeted diseases of the Newborn Metabolic Screening Programme; here we review the new programme, its history, how it operates and how GPs can best make use of it
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Albert B, Heather N, Derraik J et al. Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring. J Clin Endocrinol Metab 2013;98:3663–70.
2. Knox W. An evaluation of the treatment of phenylketonuria with diets low in phenylalanine. Pediatrics 1960;26(1).
3. Wilcken B, Haas M, Joy P et al. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet 2007;369:37–42.
4. Kwan A, Abraham R, Currier R et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014;312(7):729–38.